Presepsin: gelsolin ratio, as a promising marker of sepsis-related organ dysfunction: a prospective observational study

被引:3
作者
Ragan, Daniel [1 ,2 ]
Kustan, Peter [1 ]
Horvath-Szalai, Zoltan [1 ,3 ]
Szirmay, Balazs [1 ]
Miseta, Attila [1 ]
Woth, Gabor [2 ,4 ]
Koszegi, Tamas [1 ,3 ,5 ]
Muhl, Diana [2 ]
机构
[1] Univ Pecs, Dept Lab Med, Med Sch, Pecs, Hungary
[2] Univ Pecs, Dept Anesthesiol & Intens Therapy, Med Sch, Pecs, Hungary
[3] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary
[4] Klin Ottakring, Dept Anesthesia Intens Care & Pain Med, Vienna, Austria
[5] Univ Pecs, Natl Lab Human Reprod, Pecs, Hungary
关键词
sepsis-3; organ dysfunction; prognosis; presepsin; gelsolin; gelsolin ratio; novel biomarker; SEPTIC SHOCK; PLASMA GELSOLIN; BIOMARKERS; MORTALITY; SYSTEM; TRENDS; CARE;
D O I
10.3389/fmed.2023.1126982
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction We aimed to facilitate the diagnosis and prognosis of sepsis-related organ dysfunction through analyzing presepsin (PSEP) and gelsolin (GSN) levels along with a novel marker, the presepsin:gelsolin (PSEP:GSN) ratio.Methods Blood samples were collected from septic patients at the intensive care unit (ICU) at three time points (T1-3): T1: within 12 h after admission; T2: second day morning; T3: third day morning. Sampling points for non-septic ICU patients were T1 and T3. PSEP was measured by a chemiluminescence-based POCT method while GSN was determined by an automated immune turbidimetric assay. Data were compared with routine lab and clinical parameters. Patients were categorized by the Sepsis-3 definitions. PSEP:GSN ratio was evaluated in major sepsis-related organ dysfunctions including hemodynamic instability, respiratory insufficiency and acute kidney injury (AKI).Results In our single center prospective observational study, 126 patients were enrolled (23 control, 38 non-septic and 65 septic patients). In contrast to controls, significantly elevated (p < 0.001) admission PSEP:GSN ratios were found in non-septic and septic patients. Regarding 10-day mortality prediction, PSEP:GSN ratios were lower (p < 0.05) in survivors than in non-survivors during follow-up, while the prognostic performance of PSEP:GSN ratio was similar to widely used clinical scores (APACHE II, SAPS II, SOFA). PSEP:GSN ratios were also higher (p < 0.001) in patients with sepsis-related AKI than septic non-AKI patients during follow-up, especially in sepsis-related AKI patients needing renal replacement therapy. Furthermore, increasing PSEP:GSN ratios were in good agreement (p < 0.001) with the dosage and the duration of vasopressor requirement in septic patients. Moreover, PSEP:GSN ratios were markedly greater (p < 0.001) in patients with septic shock than in septic patients without shock. Compared to septic patients requiring oxygen supplementation, substantially elevated (p < 0.001) PSEP:GSN ratios were observed in septic patients with demand for mechanical ventilation, while higher PSEP:GSN ratios (p < 0.001) were also associated with extended periods of mechanical ventilation requirement in septic patients.Conclusion PSEP:GSN ratio could be a useful complementary marker besides the routinely used SOFA score regarding the diagnosis and short term mortality prediction of sepsis. Furthermore, the significant increase of this biomarker may also indicate the need for prolonged vasopressor or mechanical ventilation requirement of septic patients. PSEP:GSN ratio could yield valuable information regarding the extent of inflammation and the simultaneous depletion of the patient's scavenger capacity during sepsis.Clinical trail registration NIH U.S. National Library of Medicine, . Trial identifier: NCT05060679, () 23.03.2022, Retrospectively registered.
引用
收藏
页数:11
相关论文
共 43 条
  • [1] Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease
    Chebotareva, Natalia, V
    Vinogradov, Anatoliy
    Brzhozovskiy, Alexander G.
    Kashirina, Daria N.
    Indeykina, Maria I.
    Bugrova, Anna E.
    Lebedeva, Marina
    Moiseev, Sergey
    Nikolaev, Evgeny N.
    Kononikhin, Alexey S.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [2] Plasma gelsolin is reduced in trauma patients
    Dahl, B
    Schiodt, FV
    Ott, P
    Gvozdenovic, R
    Yin, HL
    Lee, WM
    [J]. SHOCK, 1999, 12 (02): : 102 - 104
  • [3] Foreword
    Eckardt, Kai-Uwe
    Kasiske, Bertram L.
    [J]. KIDNEY INTERNATIONAL SUPPLEMENTS, 2012, 2 (01) : 7 - 7
  • [4] Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study
    Endo, Shigeatsu
    Suzuki, Yasushi
    Takahashi, Gaku
    Shozushima, Tatsuyori
    Ishikura, Hiroyasu
    Murai, Akira
    Nishida, Takeshi
    Irie, Yuhei
    Miura, Masanao
    Iguchi, Hironobu
    Fukui, Yasuo
    Tanaka, Kimiaki
    Nojima, Tsuyoshi
    Okamura, Yoshikazu
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (06) : 891 - 897
  • [5] Biomarkers of sepsis
    Faix, James D.
    [J]. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2013, 50 (01) : 23 - 36
  • [6] Urinary levels of regenerating islet-derived protein III β and gelsolin differentiate gentamicin from cisplatin-induced acute kidney injury in rats
    Ferreira, Laura
    Quiros, Yaremi
    Sancho-Martinez, Sandra M.
    Garcia-Sanchez, Omar
    Raposo, Cesar
    Lopez-Novoa, Jose M.
    Gonzalez-Buitrago, Jose M.
    Lopez-Hernandez, Francisco J.
    [J]. KIDNEY INTERNATIONAL, 2011, 79 (05) : 518 - 528
  • [7] Predictive value of serum gelsolin and Gc globulin in sepsis - a pilot study
    Horvath-Szalai, Zoltan
    Kustan, Peter
    Szirmay, Balazs
    Lakatos, Agnes
    Christensen, Per Hjort
    Huber, Tamas
    Bugyi, Beata
    Muhl, Diana
    Ludany, Andrea
    Miseta, Attila
    Kovacs, Gabor L.
    Koszegi, Tamas
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2018, 56 (08) : 1373 - 1382
  • [8] Validation of an automated immune turbidimetric assay for serum gelsolin and its possible clinical utility in sepsis
    Horvath-Szalai, Zoltan
    Kustan, Peter
    Szirmay, Balazs
    Lakatos, Agnes
    Christensen, Per H.
    Huber, Tamas
    Bugyi, Beata
    Muhl, Diana
    Ludany, Andrea
    Miseta, Attila
    Kovacs, Gabor L.
    Koszegi, Tamas
    [J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (03)
  • [9] Antagonistic sepsis markers: Serum gelsolin and actin/gelsolin ratio
    Horvath-Szalai, Zoltan
    Kustan, Peter
    Muehl, Diana
    Ludany, Andrea
    Bugyi, Beata
    Koszegi, Tamas
    [J]. CLINICAL BIOCHEMISTRY, 2017, 50 (03) : 127 - 133
  • [10] Presepsin:albumin ratio and C-reactive protein:albumin ratio as novel sepsis-based prognostic scores A retrospective study
    Kaplan, Mustafa
    Duzenli, Tolga
    Tanoglu, Alpaslan
    Guney, Basak Cakir
    Tastan, Yesim Onal
    Bicer, Hatice Selcen
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (7-8) : 182 - 187